Cargando…

Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential

Rapastinel, formerly Glyx-13, is a novel positive allosteric modulator of the N-methyl-D-aspartate-receptor (NMDAR) that counteracts psychotomimetic actions of NMDAR antagonists. We set out to evaluate the effect of rapastinel alone or in combination with the global and GluN2B subunit–specific NMDAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasilescu, Andrei-Nicolae, Pfeiffer, Natascha, Terraneo, Federica, Riva, Marco Andrea, Lang, Undine E, Inta, Dragos, Gass, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670745/ https://www.ncbi.nlm.nih.gov/pubmed/35974297 http://dx.doi.org/10.1093/ijnp/pyac051

Ejemplares similares

Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
por: Vasilescu, Andrei-Nicolae, et al.
Publicado: (2017)

Cre-Activation in ErbB4-Positive Neurons of Floxed Grin1/NMDA Receptor Mice Is Not Associated With Major Behavioral Impairment
por: Mallien, Anne S., et al.
Publicado: (2021)

The impact of handling technique and handling frequency on laboratory mouse welfare is sex-specific
por: Sensini, Federica, et al.
Publicado: (2020)

Inducible forebrain-specific ablation of the transcription factor Creb during adulthood induces anxiety but no spatial/contextual learning deficits
por: Vogt, Miriam A., et al.
Publicado: (2014)

F196. DIFFERENTIAL EFFECTS OF MGLU5 RECEPTOR BLOCKADE ON BEHAVIOR, SCHIZOPHRENIA-RELEVANT GENE EXPRESSION AND NEURONAL ACTIVATION PATTERNS FROM DEVELOPMENT TO AGING MICE
por: Inta, Dragos, et al.
Publicado: (2018)

Social isolation in rats: Effects on animal welfare and molecular markers for neuroplasticity
por: Begni, Veronica, et al.
Publicado: (2020)

Correction: Social isolation in rats: Effects on animal welfare and molecular markers for neuroplasticity
por: Begni, Veronica, et al.
Publicado: (2021)

Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity
por: Hassouna, Rim, et al.
Publicado: (2013)

Comparative Severity Assessment of Genetic, Stress-Based, and Pharmacological Mouse Models of Depression
por: Mallien, Anne Stephanie, et al.
Publicado: (2022)

Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis
por: Heekeren, Karsten, et al.
Publicado: (2008)

Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants
por: Ricken, Roland, et al.
Publicado: (2017)

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
por: Poleszak, Ewa, et al.
Publicado: (2016)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
por: Pringle, A, et al.
Publicado: (2012)

Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
por: Pozzi, Laura, et al.
Publicado: (2014)

Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
por: Gordillo-Salas, Marta, et al.
Publicado: (2018)

Perinatal Hypoxia and Ischemia in Animal Models of Schizophrenia
por: Hefter, Dimitri, et al.
Publicado: (2018)

Allosteric antagonist action at triheteromeric NMDA receptors
por: Gibb, Alasdair J.
Publicado: (2022)

Correction: Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
Publicado: (2014)

S181. ANALYSIS OF THE AMELIORATING EFFECT OF D-SERINE ON GLUN2D DEFICIENT MICE
por: Mallien, Anne, et al.
Publicado: (2020)

Ketogenic diet for mood disorders from animal models to clinical application
por: Smolensky, Ilya V., et al.
Publicado: (2023)

Antidepressant Interactions with the NMDA NR1-1b Subunit
por: Raabe, Richard, et al.
Publicado: (2008)

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action
por: Aleksandrova, Lily R., et al.
Publicado: (2017)

Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice
por: Stasiuk, Weronika, et al.
Publicado: (2016)

NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses
por: Autry, Anita E., et al.
Publicado: (2011)

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
por: Wei, Yan, et al.
Publicado: (2021)

Binding Affinity and Mechanisms of Potential Antidepressants Targeting Human NMDA Receptors
por: Ye, Simin, et al.
Publicado: (2023)

Mechanical stress activates NMDA receptors in the absence of agonists
por: Maneshi, Mohammad Mehdi, et al.
Publicado: (2017)

Pediatric anti-NMDA receptor encephalitis is seasonal
por: Adang, Laura A, et al.
Publicado: (2014)

Interactions of a Dopamine D(1) Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat
por: McMillen, Brian A., et al.
Publicado: (2013)

Dopamine Transporter Knockout Rats Show Impaired Wellbeing in a Multimodal Severity Assessment Approach
por: Mallien, Anne Stephanie, et al.
Publicado: (2022)

NMDA Receptor Signaling Mediates cFos Expression via Top2β-Induced DSBs in Glioblastoma Cells
por: Lutz, Henrik, et al.
Publicado: (2019)

Modulation of Functional EEG Networks by the NMDA Antagonist Nitrous Oxide
por: Kuhlmann, Levin, et al.
Publicado: (2013)

NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
por: Vanle, Brigitte, et al.
Publicado: (2018)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
por: Bartsch, Caitlyn J., et al.
Publicado: (2022)

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade
por: Nosyreva, Elena, et al.
Publicado: (2014)

The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver
por: Bromek, Ewa, et al.
Publicado: (2021)

Psychogenic Stress Activates C-Fos in Nucleus Accumbens-Projecting Neurons of the Hippocampal Ventral Subiculum
por: Lipski, Witold J, et al.
Publicado: (2017)

Muscle agonist–antagonist interactions in an experimental joint model
por: Gorkovenko, Andrei V., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v3bh1bvj3ioujlmqnkbvdu1k4f